First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study

Conditions

• Idiopathic Growth Hormone Deficiency
• Turner Syndrome

Interventions

• OTHER: Blood sampling

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

• [object Object]